Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2017 Dec;10(12):e004148. doi: 10.1161/CIRCOUTCOMES.117.004148

Table 2.

Comparison of KCCQ Score Between Treatment Groups

Telemonitoring Usual Care Total
(n =756) (n=765) (N=1521) P value
KCCQ Overall Summary Score– mean±s.d.
 Baseline 60.7 ± 24.1 58.6 ± 24.9 59.6 ± 24.5 0.11
 3-months 69.9 ± 24.5 67. 9 ± 25.8 68.9 ± 25.2 0.15
 6-months 72.3 ± 24.4 68.5 ± 26.4 70.4 ± 25.5 0.01
KCCQ Physical Limitations– mean±s.d.
 Baseline 69.6 ± 27.8 68.7 ± 28.5 69.1 ± 28.2 0.55
 3-months 75.8 ± 27.3 75.1 ± 27.2 75.5 ± 27.2 0.70
 6-months 77.1 ± 26.1 74.9 ± 27.9 76.0 ± 27.0 0.18
KCCQ Total Symptom Score– mean±s.d.
 Baseline 64.2 ± 26.7 60.6 ± 28.4 62.4 ± 27.6 0.02
 3-months 72.2 ± 26.3 69.4 ± 27.6 70.9 ± 27.0 0.07
 6-months 74.0 ± 26.0 69.6 ± 28.9 71.8 ± 27.5 0.007
KCCQ Self-Efficacy– mean±s.d.
 Baseline 83.1 ± 20.9 82.9 ± 20.3 83.0 ± 20.6 0.88
 3-months 86.2 ± 18.8 87.1 ± 17.5 86.6 ± 18.2 0.39
 6-months 88.5 ± 18.1 87.1 ± 17.8 87.8 ± 18.0 0.23
KCCQ Quality of Life– mean±s.d.
 Baseline 54.4 ± 26.9 53.8 ± 27.3 54.1 ± 27.1 0.65
 3-months 66.2 ± 28.0 64.5 ± 28.8 65.4 ± 28.4 0.32
 6-months 68.7 ± 27.1 65.2 ± 29.4 67.0 ± 28.3 0.04
KCCQ Social Limitations – mean±s.d.
 Baseline 56.6 ± 33.2 53.0 ± 33.0 54.8 ± 33.1 0.06
 3-months 66.4 ± 31.2 65.4 ± 32.8 65.9 ± 32.0 0.61
 6-months 69.7 ± 31.3 66.6 ± 32.1 68.1 ± 31.7 0.12

Abbreviations: KCCQ, Kansas City Cardiomyopathy Questionnaire; s.d., standard deviation